Results 121 to 130 of about 13,117,018 (331)
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley +1 more source
PO40 | Management of paediatric patients affected by mild factor VII deficiency undergoing surgery
Introduction: Identifying perioperative bleeding risk in a pediatric population undergoing surgery is quite complex, as clinical history is often not particularly informative and laboratory tests can be influenced by multiple pre-analytical variables ...
doaj +1 more source
INTRODUCTION: During extrinsic coagulation pathway, a complex is developed between factor VII, calcium and tissue factor (a cell membrane lipoprotein that is exposed after cell injury).
S Asgary +4 more
doaj
Rare coagulation disorders: fibrinogen, factor VII and factor XIII
P. Moerloose, J. Schved, D. Nugent
semanticscholar +1 more source
IqgC is a RasGAP from Dictyostelium discoideum. IqgC binds RasG via its RasGAP domain and deactivates it on macroendocytic cups, thereby suppressing the uptake of fluid and particles. IqgC has a positive effect on cell‐substratum adhesion, and its RGCt domain is required for recruitment to ventral foci.
Vedrana Filić +3 more
wiley +1 more source
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
S. Mayer +7 more
semanticscholar +1 more source
CDT1 is an essential protein for DNA replication licensing that loads the MCM complex, the eukaryotic replicative DNA helicase, onto replication origins. Overexpression of CDT1 induces cell cycle arrest at the S phase. Here we showed CDT1 inhibits the progression of replication forks by interacting with the MCM complex, leading to the stalling and ...
Takashi Tsuyama +7 more
wiley +1 more source
Development and Applications of Recombinant Activated Factor VII
Recombinant activated factor VII (rFVIIa) was initially developed for treatment and prevention of bleeding during surgery and invasive procedures in congenital hemophilia with inhibitors against coagulation factors.
Nutjeera Intasai
doaj

